GAMEC – a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours-Reference-Cited by-同舟云学术

GAMEC – a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours

Published:2007-07-03 Issue:3 Volume:97 Page:308-314
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Shamash J,Powles T,Ansell W,Stebbing J,Mutsvangwa K,Wilson P,Asterling S,Liu S,Wyatt P,Joel S P,Oliver R T D

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6603865.pdf

Reference29 articles.

1. Anthoney DA, McKean MJ, Roberts JT, Hutcheon AW, Graham J, Jones W, Paul J, Kaye SB (2004) Bleomycin, vincristine, cisplatin/bleomycin, etoposide, cisplatin chemotherapy: an alternating, dose intense regimen producing promising results in untreated patients with intermediate or poor prognosis malignant germ-cell tumours. Br J Cancer 90: 601–606

2. Atkinson CH, Horwich A, Peckham MJ (1987) Methotrexate for relapse of metastatic non-seminomatous germ-cell tumours. Med Oncol Tumor Pharmacother 4: 33–37

3. Bedano P, Brames M, Williams S, Einhorn L (2005) A phase II study of cisplatin plus epirubicin salvage chemotherapy in refractory germ cell tumors. J Clin Oncol 23, ASCO Abstract, 4526

4. Bhatia S, Abonour R, Porcu P, Seshadri R, Nichols C, Cornetta K, Einhorn L (2000) High dose chemotherapy as initial salvage chemotherapy in patients with relapsed testicular cancer. J Clin Oncol 18: 3346–3351

5. Bower M, Newlands ES, Holden L, Rustin GJ, Begent RH (1997) Treatment of men with metastatic non-seminomatous germ cell tumours with cyclical POMB/ACE chemotherapy. Ann Oncol 8: 477–483

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming Chemotherapy Resistance in Germ Cell Tumors;Biomedicines;2022-04-22

2. Management of Late Relapses After Chemotherapy in Testicular Cancer: Optimal Outcomes with Dose-intense Salvage Chemotherapy and Surgery;European Urology Focus;2021-07

3. Gemcitabine, Oxaliplatin and Paclitaxel (GemPOx) in Patients with Relapsed or Refractory Germ Cell Tumors After High Dose Chemotherapy, A Retrospective Single-Center Experience;International Journal of Hematology and Oncology;2020-12-30

4. Brain metastases from germ cell tumor: time to reconsider radiotherapy?;Critical Reviews in Oncology/Hematology;2020-06

5. Dose-dense chemotherapy for untreated poor-prognosis and relapsed germ-cell tumours: an 18-year experience with GAMEC chemotherapy;BJU International;2020-05-04